Anthony Petrone Analyst PerformanceAnalyst at EvercoreAnthony Petrone is a stock analyst at Evercore focused in the medical sector, covering 31 publicly traded companies. Over the past year, Anthony Petrone has issued 75 stock ratings, including buy and hold recommendations. While full access to Anthony Petrone's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Anthony Petrone's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings98 Last 10 YearsBuy Recommendations80.68% 71 Buy RatingsCompanies Covered31 Unique Companies Ratings Distribution88RatingsDistribution of strong buy, buy, hold, and sell ratings by Anthony Petrone.RatingPercentageCount Strong Buy0.0%0 ratings Buy80.7%71 ratings Hold19.3%17 ratings Sell0.0%0 ratingsOut of 88 total stock ratings issued by Anthony Petrone at Evercore, the majority (80.7%) have been Buy recommendations, followed by 19.3% Hold.Best & Worst CallsBest Call0000.0%ADMASep 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%SENSApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ67.7% of companies on NASDAQ21 companiesNYSE32.3% of companies on NYSE10 companiesAnthony Petrone, an analyst at Evercore, currently covers 31 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical29 companies93.5%Manufacturing2 companies6.5%Anthony Petrone of Evercore specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED INSTRUMENTS10 companies32.3%MED PRODUCTS8 companies25.8%MED - BIOMED/GENE6 companies19.4%MED/DENTAL - SUPP2 companies6.5%MEDICAL SERVICES2 companies6.5%MEDICAL INFO SYS1 company3.2%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company3.2%INDUSTRIAL MEASUREMENT INSTRUMENTS & RELATED PRODUCTS1 company3.2% Anthony Petrone's Ratings History at Evercore Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsSTAASTAAR Surgical5/14/2026Boost Price Target$29.40$27.00Neutral$0.0000.00% ROITNDMTandem Diabetes Care5/8/2026Set Price Target$17.16$24.00$0.0000.00% ROILNTHLantheus5/8/2026Boost Price Target$91.00$100.00Outperform$0.0000.00% ROIADMAADMA Biologics5/7/2026Lower Price Target$10.08$20.00Outperform$0.0000.00% ROIALCAlcon5/7/2026Lower Price Target$65.66$85.00Outperform$0.0000.00% ROIMNKDMannKind5/7/2026Lower Price Target$3.56$7.00Outperform$0.0000.00% ROILIVNLivaNova5/7/2026Boost Price Target$66.26$90.00Outperform$0.0000.00% ROIEMBCEmbecta5/6/2026Lower Price Target$3.97$5.00Neutral$0.0000.00% ROIINSPInspire Medical Systems5/5/2026Lower Price Target$54.77$55.00Outperform$0.0000.00% ROIDXCMDexCom5/1/2026Set Price Target$61.10$75.00$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. GEHCGE HealthCare Technologies4/30/2026Lower Price Target$60.46$80.00$0.0000.00% ROIRMDResMed4/13/2026Set Price Target$228.65$255.00Outperform$0.0000.00% ROIMNKDMannKind4/13/2026Lower Price Target$2.59$8.00Outperform$0.0000.00% ROIMDTMedtronic4/13/2026Lower Price Target$86.76$120.00Outperform$0.0000.00% ROILNTHLantheus4/13/2026Boost Price Target$80.60$95.00Outperform$0.0000.00% ROIISRGIntuitive Surgical4/13/2026Set Price Target$451.13$525.00Neutral$0.0000.00% ROIINSPInspire Medical Systems4/13/2026Lower Price Target$53.44$70.00Outperform$0.0000.00% ROIHAEHaemonetics4/13/2026Lower Price Target$57.36$70.00Outperform$0.0000.00% ROIGEHCGE HealthCare Technologies4/13/2026Lower Price Target$72.71$90.00Outperform$0.0000.00% ROIEWEdwards Lifesciences4/13/2026Set Price Target$77.27$95.00Outperform$0.0000.00% ROIEMBCEmbecta4/13/2026Lower Price Target$9.04$12.00Neutral$0.0000.00% ROIBSXBoston Scientific4/13/2026Lower Price Target$62.05$90.00Outperform$0.0000.00% ROIADMAADMA Biologics4/13/2026Lower Price Target$10.26$24.00Outperform$0.0000.00% ROIMMEDMiniMed Group3/31/2026Initiated Coverage$14.35$21.00Outperform$0.0000.00% ROILNTHLantheus2/27/2026Boost Price Target$75.78$85.00Outperform$0.0000.00% ROIESTAEstablishment Labs2/25/2026Boost Price Target$80.66$100.00Outperform$0.0000.00% ROITNDMTandem Diabetes Care2/20/2026Set Price Target$23.55$22.00Neutral$0.0000.00% ROIDXCMDexCom2/13/2026Boost Price Target$65.08$90.00Outperform$0.0000.00% ROIINSPInspire Medical Systems2/12/2026Lower Price Target$68.50$85.00Outperform$0.0000.00% ROIHAEHaemonetics2/6/2026Lower Price Target$65.00$80.00Outperform$0.0000.00% ROIBSXBoston Scientific2/5/2026Lower Price Target$75.50$115.00Outperform$0.0000.00% ROIEXASExact Sciences1/20/2026Reiterated Rating$102.43$105.00Neutral$0.0000.00% ROIEXASExact Sciences1/20/2026Downgrade$102.35$105.00Neutral$0.0000.00% ROIGHGuardant Health1/9/2026Set Price Target$108.74$135.00$0.0000.00% ROIINSPInspire Medical Systems12/17/2025Boost Price Target$115.53$130.00Outperform$0.0000.00% ROIHAEHaemonetics12/17/2025Boost Price Target$80.93$90.00Outperform$0.0000.00% ROIGHGuardant Health12/17/2025Boost Price Target$100.00$120.00Outperform$0.0000.00% ROIESTAEstablishment Labs12/17/2025Boost Price Target$74.15$90.00Outperform$0.0000.00% ROIDXCMDexCom12/17/2025Boost Price Target$66.37$78.00Outperform$0.0000.00% ROITNDMTandem Diabetes Care12/17/2025Boost Price Target$22.60$21.00Neutral$0.0000.00% ROIOne filing just changed the SpaceX IPO forever (Ad)SpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the largest in history. The 21-bank syndicate has already locked up shares, so retail investors won't get access. But the S-1 exposed one publicly traded company Musk cannot operate without - and it's still cheap. Dylan Jovine is releasing the ticker free before June 12 changes the price.Get the ticker before the SpaceX IPO reprices everything on June 12MDXGMiMedx Group12/17/2025Lower Price Target$7.25$10.00Outperform$0.0000.00% ROILIVNLivaNova12/17/2025Boost Price Target$63.08$72.00Outperform$0.0000.00% ROILNTHLantheus12/17/2025Boost Price Target$65.17$72.00Outperform$0.0000.00% ROICOOCooper Companies12/5/2025Set Price Target$77.03$100.00Outperform$0.0000.00% ROIAXGNAxoGen12/1/2025Initiated Coverage$29.00$40.00Outperform$0.0000.00% ROIAXGNAxoGen12/1/2025Initiated Coverage$27.69$40.00Outperform$0.0000.00% ROILIVNLivaNova11/13/2025Boost Price Target$56.62$70.00Outperform$0.0000.00% ROIALCAlcon11/11/2025Lower Price Target$76.39$100.00Outperform$0.0000.00% ROIESTAEstablishment Labs11/6/2025Boost Price Target$60.51$85.00Outperform$0.0000.00% ROIINSPInspire Medical Systems11/4/2025Set Price Target$73.76$110.00$0.0000.00% ROIRMDResMed10/31/2025Lower Price Target$252.14$300.00Outperform$0.0000.00% ROIEWEdwards Lifesciences10/31/2025Boost Price Target$83.53$100.00Outperform$0.0000.00% ROIHOLXHologic10/23/2025Downgrade$73.93$78.00Neutral$0.0000.00% ROIISRGIntuitive Surgical10/22/2025Set Price Target$540.05$575.00$0.0000.00% ROIABTAbbott Laboratories10/14/2025Boost Price Target$132.00$140.00Neutral$0.0000.00% ROIGHGuardant Health9/25/2025Boost Price Target$61.55$70.00Outperform$0.0000.00% ROIALCAlcon8/21/2025Lower Price Target$79.26$110.00Outperform$0.0000.00% ROIHAEHaemonetics8/8/2025Lower Price Target$55.49$70.00Outperform$0.0000.00% ROILNTHLantheus8/7/2025Lower Price Target$51.87$70.00Outperform$0.0000.00% ROIRMDResMed8/1/2025Boost Price Target$279.57$290.00Outperform$0.0000.00% ROITFXTeleflex8/1/2025Boost Price Target$114.60$135.00Neutral$0.0000.00% ROIHOLXHologic7/31/2025Set Price Target$67.25$75.00$0.0000.00% ROIEWEdwards Lifesciences7/25/2025Boost Price Target$78.75$95.00Outperform$0.0000.00% ROIEWEdwards Lifesciences7/16/2025Boost Price Target$76.90$87.00Outperform$0.0000.00% ROIDXCMDexCom7/16/2025Boost Price Target$84.78$100.00Outperform$0.0000.00% ROIABTAbbott Laboratories7/16/2025Boost Price Target$131.41$140.00Neutral$0.0000.00% ROIRMDResMed7/16/2025Boost Price Target$251.98$270.00Outperform$0.0000.00% ROIMDTMedtronic7/16/2025Boost Price Target$89.26$100.00Outperform$0.0000.00% ROIHOLXHologic7/16/2025Boost Price Target$63.26$70.00Outperform$0.0000.00% ROIESTAEstablishment Labs7/16/2025Boost Price Target$44.42$70.00Outperform$0.0000.00% ROIEMBCEmbecta7/16/2025Lower Price Target$9.58$12.00Neutral$0.0000.00% ROICOOCooper Companies7/16/2025Lower Price Target$72.20$90.00Outperform$0.0000.00% ROITFXTeleflex7/16/2025Lower Price Target$113.50$130.00Neutral$0.0000.00% ROISTAASTAAR Surgical7/16/2025Boost Price Target$16.86$18.00Neutral$0.0000.00% ROIMDTMedtronic5/22/2025Lower Price Target$81.67$98.00Outperform$00.0000.00% ROITFXTeleflex4/16/2025Set Price Target$128.22$155.00$000.0000.00% ROIRMDResMed4/16/2025Set Price Target$211.79$265.00$000.0000.00% ROIEMBCEmbecta4/10/2025Initiated Coverage$12.65$15.00Neutral$0.0000.00% ROIGHGuardant Health4/10/2025Initiated Coverage$43.87$55.00Outperform$00.0000.00% ROISENSSenseonics Holdings, Inc. Common Stock4/10/2025Initiated Coverage$12.05$40.00Outperform$0.0000.00% ROITNDMTandem Diabetes Care4/10/2025Initiated Coverage$17.61$20.00Neutral$00.0000.00% ROIDXCMDexCom4/10/2025Initiated Coverage$66.84$85.00Outperform$00.0000.00% ROIEXASExact Sciences4/10/2025Initiated Coverage$45.50$60.00Outperform$0.0000.00% ROIALCAlcon3/28/2025Boost Price Target$96.95$120.00Outperform$00.0000.00% ROITARSTarsus Pharmaceuticals3/6/2025Boost Price Target$43.57$58.00Buy$00.0000.00% ROILIVNLivaNova2/26/2025Lower Price Target$41.16$60.00Outperform$00.0000.00% ROIGKOSGlaukos2/19/2025Upgrade$153.00$200.00Outperform$000.0000.00% ROIISRGIntuitive Surgical10/17/2024Boost Price Target$474.85$500.00$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupThe Goldman Sachs GroupDeutsche Bank AktiengesellschaftCLSAWall Street ZenCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupTD CowenTruist FinancialPiper Sandler Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
